Cerence Inc.CRNCNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank60
5Y CAGR-4.8%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
-4.8%/yr
Long-term compound
Percentile
P60
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM18.56%+291.0%
20254.75%+102.8%
2024-169.36%-8834.4%
2023-1.90%+96.1%
2022-48.92%-306.1%
202123.74%+164.2%
20208.99%-32.0%
201913.20%-41.5%
201822.59%-33.3%
201733.86%-